Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation

<div>The protein expression of IL-17, IL-18, IFN-<i>γ</i>, MMP-8, and MMP-9 in tracheal graft of different groups of mouse heterotopic tracheal transplantation model determined by western blot analysis. (a) Isograft group; (b) allograft group; (c) allograft+ tacrolimus group; (d) allograft+azithromycin group; (e) allograft+tacrolimus+azithromycin group.</div>

Disease Markers

fig5

Figure 5

Figure 5: Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation 

Figure 5 | Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation 